Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two ...
Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price ...
By Nancy Lapid Sept 15 (Reuters) - Hello Health Rounds readers! Today we highlight a potentially game-changing experimental ...
Moderna and Merck's Phase 3 melanoma vaccine trial showed positive results, but full data and FDA approval are still pending ...
If a new drug's the survival benefit is confirmed in the next leg of a late-stage study, the drug could provide a ...
Cancer science made major progress in the past year but faces an “inflection point” amid funding threats, according to a ...
Women with incurable breast cancer will be given a life-extending drug on the NHS after health-spending watchdogs reversed a ...
Blood test shows promise in detecting pancreatic cancer early—a 'Holy Grail' for the field Pancreatic cancer is typically ...
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...
A Minnesota woman diagnosed with stage 3B ovarian cancer after her best friend died from the same disease urges women to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results